Skip to main content
OpenTrials

Clinical trial condition

Phase II Cohort A: Relapsed or Refractory Mantle Cell Lymphoma

Explore clinical trials studying Phase II Cohort A: Relapsed or Refractory Mantle Cell Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Phase II Cohort A: Relapsed or Refractory Mantle Cell Lymphoma trial results

Active, Not Recruiting

Study of Acalabrutinib in Chinese Adult Subjects With Relapsed or Refractory Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia or Other B-cell Malignancies

NCT03932331

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • Research Site Beijing, China
  • Research Site Beijing, China
  • Research Site Beijing, China
  • Research Site Changchun, China
View all 23 locations
View Trial Details

Related conditions